| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $840.0M | — | +41.5% |
| Cost of Revenue | $517.3M | — | +50.7% |
| Gross Profit | $322.7M | — | +28.8% |
| R&D Expense | $20.2M | — | +27.0% |
| SG&A Expense | $191.1M | — | +21.6% |
| Operating Income | $111.4M | — | +43.9% |
| Pre-tax Income | $82.7M | — | -28.6% |
| Income Tax | $26.7M | — | +50.0% |
| Net Income | $55.9M | — | -43.0% |
| EPS (Basic) | $0.23 | — | -42.5% |
| EPS (Diluted) | $0.23 | — | -42.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $177.3M | -71.7% | -64.5% |
| Accounts Receivable | $676.9M | +30.8% | +48.9% |
| Inventory | $421.6M | +43.1% | +56.2% |
| Current Assets | $1.46B | -7.8% | +7.2% |
| Total Assets | $5.74B | +12.5% | +19.7% |
| Current Liabilities | $543.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$66.6M | — | -356.2% |
| Capital Expenditures | $25.1M | — | +128.2% |
| Investing Cash Flow | -$889.3M | — | -363.4% |
| Financing Cash Flow | $507.8M | — | +323.4% |
| Free Cash Flow | -$91.7M | — | -711.3% |
| +57.7% |
| Long-term Debt | $2.06B | +25.8% | +26.8% |
| Total Liabilities | $2.99B | +23.9% | +32.2% |
| Stockholders' Equity | $2.73B | +2.3% | +8.5% |